New directions in the prevention and treatment of schizophrenia: A biological perspective

被引:16
作者
Wyatt, RJ [1 ]
Apud, JA [1 ]
Potkin, S [1 ]
机构
[1] UNIV CALIF IRVINE,MED CTR,CALIF COLL MED,DEPT PSYCHIAT & BEHAV,IRVINE,CA 92717
来源
PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES | 1996年 / 59卷 / 04期
关键词
D O I
10.1080/00332747.1996.11024774
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
OUR current treatments for schizophrenia are, at best, palliative. With the exception of counseling those families with a known high risk for having schizophrenic offspring, no preventive measures are currently available. The not too distant future, however, promises to bring improvements in somatic treatments as well as the possible introduction of preventive measures. We are fully aware that current biological treatments work best when they are combined with psychosocial intervention, and expect that future biological treatments and preventions will also involve appropriate nonbiological considerations. Psychosocial treatments are covered elsewhere in this issue. Here we look at how modern genetics, pre- and perinatal factors, early and sustained intervention, and new medications are likely to decrease both the number of individuals with schizophrenia and the severity of the illness.
引用
收藏
页码:357 / 370
页数:14
相关论文
共 85 条
[1]   EPIDEMIOLOGIC EVIDENCE THAT MATERNAL INFLUENZA CONTRIBUTES TO THE ETIOLOGY OF SCHIZOPHRENIA - AN ANALYSIS OF SCOTTISH, ENGLISH, AND DANISH DATA [J].
ADAMS, W ;
KENDELL, RE ;
HARE, EH ;
MUNKJORGENSEN, P .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :522-534
[2]  
AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P178
[3]  
AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169
[4]  
ANGRIST B, 1990, PROGR PSYCHIAT
[5]  
[Anonymous], RECEPTOR TABLES
[6]  
ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235
[7]  
BARR CE, 1990, ARCH GEN PSYCHIAT, V47, P869
[8]   CHROMOSOMAL-ABERRATIONS AND SCHIZOPHRENIA - AUTOSOMES [J].
BASSETT, AS .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 161 :323-334
[9]  
BEASLEY CM, IN PRESS NEUROPSYCHO
[10]  
BORISON RL, 1996, CLIN PSYCHOPHARMACOL, V16, P158